Carcinoma, Hepatocellular: all 3,251 studies
Page 17 of 33. Open to participants first (976), then studies with results posted, then the rest; newest registration first within each.
- Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCCStatus unknownNCT05420922
- A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in ArizonaWithdrawnNCT05418387Not applicable
- Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular CarcinomaStatus unknownNCT05416073Phase 4
- Effect of PD-1 /PD-L1 Inhibitor Therapy Before Liver Transplantation on Acute Rejection After Liver Transplantation in Patients With Hepatocellular CarcinomaStatus unknownNCT05411926
- Effects of Antiviral Therapy on Patients With HBV-related HCCCompletedNCT05406089
- Radiofrequency Ablation With Gradual Radiofrequency Energy Increment for Hepatocellular Carcinoma TreatmentStatus unknownNCT05397860Not applicable
- Efficacy and Safety of T+A+RAD in HCCStatus unknownNCT05396937Phase 2
- A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast CancerActive, not recruitingNCT05394259Phase 1
- Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular CarcinomaStatus unknownNCT05391867Not applicable
- Cohort Study of Patients With Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of ChemoembolizationStatus unknownNCT05390112
- Pembrolizumab and Lenvatinib for Resectable Hepatocellular CarcinomaActive, not recruitingNCT05389527Phase 2
- Next Generation " Pre-clinical Model for Colorectal Cancer Metastases and Hepatocellular CarcinomasCompletedNCT05384184
- Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Patients With Advanced Liver CancerStatus unknownNCT05383066
- Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC PatientsActive, not recruitingNCT05377034Phase 2
- Possible Differences in HCC Course Depending on DAA TreatmentStatus unknownNCT05376943
- A Study of exoASO-STAT6 (CDK-004) in Patients With Advanced Hepatocellular Carcinoma (HCC) and Patients With Liver Metastases From EIther Primary Gastric Cancer or Colorectal Cancer (CRC)TerminatedNCT05375604Phase 1
- A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver CancerActive, not recruitingNCT05371873
- A Clinical Study to Observe the Effectiveness and Safety of IBI310, Bevacizumab Combined With Sintilimab in the Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT05363722Phase 1
- Prognosis Analysis of Elderly Donor Liver in Liver TransplantationCompletedNCT05355662
- Bevacizumab Biosimilar Plus FOLFOX4 in the Treatment of Recurrent HCC After Liver TransplantationStatus unknownNCT05355155Phase 2
- GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular CarcinomaTerminatedNCT05352542Phase 1
- Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular CarcinomasCompletedNCT05352204
- Watch and Wait and Surgical Treatment for Clinical Complete Responders After Non-Curative Therapy for Hepatocellular CarcinomaCompletedNCT05349331Phase 2
- Himalaya Early Access ProgramApproved for marketingNCT05345678
- TACE Combined With Penpulimab and Anlotinib for Advanced HCCStatus unknownNCT05344924Phase 2/3
- Novel GPC3 CAR-T Cell Therapy for Hepatocellular CarcinomaStatus unknownNCT05344664Phase 1
- Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma PatientsStatus unknownNCT05343832
- International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid BiopsyTerminatedNCT05342350
- IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver TransplantationStatus unknownNCT05339581Not applicable
- Autologous HBV-specific T Cell Receptor Engineered T Cells (TCR-T) in Patients With HBV-related Advanced HCCStatus unknownNCT05339321Phase 1
- TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCCCompletedNCT05332821
- TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCCCompletedNCT05332496
- Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular CarcinomaWithdrawnNCT05327738Phase 2
- A Study of TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular CarcinomaActive, not recruitingNCT05320692Phase 3
- A Phase II Study of AK104 Plus Lenvatinib and TACE in HCCActive, not recruitingNCT05319431Phase 2
- Durvalumab Plus Lenvatinib as First-line Treatment for Unresectable Hepatocellular CarcinomaStatus unknownNCT05312216Phase 2
- HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After ResectionStatus unknownNCT05311319Phase 2
- Postoperative Adjuvant Therapy of HCC Based on PD-1CompletedNCT05307926
- Multi-Detector CT Angiography With 3D Reconstruction Versus Digital Subtraction AngiographyCompletedNCT05304572
- Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCCActive, not recruitingNCT05301842Phase 3
- Circulating Tumor Cell Detection in Hepatocellular CarcinomaCompletedNCT05297955
- Pharmacogenetic Study in Hepatocellular Carcinoma Patients.CompletedNCT05291338
- HLX07 Combination Therapy or Motherapy in Patient With Advanced Hepatocellular CarcinomaStatus unknownNCT05290220Phase 2
- The Surveillance of Hepatocellular CarcinomaStatus unknownNCT05286099
- Surufatinib Alone or Combined With Anti-PD-1 mAb in the Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT05282433Phase 2
- A Phase I, Open-label Study to Assess the Safety and Efficacy of Poly-ICLC Plus Nivolumab in Unresectable Hepatocellular Carcinoma PatientsStatus unknownNCT05281926Phase 1
- RFA for Treatment of Intermediate Stage HCCCompletedNCT05281783Not applicable
- Lipiodol-TACE With Idarubicin for Hepatocellular CarcinomaStatus unknownNCT05280444Phase 2/3
- Assessing the Prognosis of TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for HCC by Using Clinical and Imaging BiomarkersStatus unknownNCT05278195
- Radiofrequency Ablation Plus Systematic Neoadjuvant Therapy for Recurrent Hepatocellular Carcinoma (RANT Study)Status unknownNCT05277675Not applicable
- Plan for Microwave Thermal FieldStatus unknownNCT05270642Not applicable
- Registry on Percutaneous ElectrochemotherapyActive, not recruitingNCT05267080
- Clinical Intervention Strategy for High-risk Group of Hepatitis B Related Hepatocellular CarcinomaStatus unknownNCT05256459
- BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation TherapyCompletedNCT05250895Early Phase 1
- Clinical Study of MAK Immune Cells in the Treatment of PHCStatus unknownNCT05242757Not applicable
- Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent HepatocarcinomaStatus unknownNCT05240404Phase 2
- Treat Primary and Metastatic Liver TumorsWithdrawnNCT05240040
- OREIOS International StudyCompletedNCT05239507
- Identification of Image Phenotypes to Predict Recurrence After Resection of Hepatocellular CarcinomaCompletedNCT05235490
- HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or FailureStatus unknownNCT05233358Not applicable
- Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular CarcinomaStatus unknownNCT05231382Phase 3
- A Study of HFB301001 in Adult Patients With Advanced Solid TumorsTerminatedNCT05229601Phase 1
- A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) ParticipantsCompletedNCT05225207
- Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver TumorsTerminatedNCT05220722Phase 1/2
- TACE Combined With Lenvatinib Versus TACE Sequential Lenvatinib in the Treatment of Intermediate/Advanced Liver CancerStatus unknownNCT05220020Phase 3
- A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET)Status unknownNCT05214339Phase 2
- Expanded Activated Lymphocytes (EAL) as Adjuvant Therapy in Patients With HCC at High Risk of Recurrence After Radical ResectionStatus unknownNCT05213637Phase 2
- Study on Therapeutic Effect of Combination of Envafolimab, Lenavatinib and TACE in Advanced HCC PatientsCompletedNCT05213221Phase 2
- A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCCStatus unknownNCT05205629
- A Single Center Real-world Study of Donafenib in the Treatment of Hepatocellular Carcinoma in Routine Clinical PracticeStatus unknownNCT05200221
- A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + BevacizumabTerminatedNCT05199285Phase 2
- Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized TrialActive, not recruitingNCT05198609Phase 3
- Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Systemic TherapyCompletedNCT05197504
- Long-term Outcomes of Ablation, Liver Resection, and Liver Transplant as First-line Treatment for Solitary HCC of 3 cm or LessCompletedNCT05193253
- A Study of Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular CarcinomaActive, not recruitingNCT05185531Phase 1
- Utilization of MAsS in Patients Undergoing LT for HCCTerminatedNCT05184283
- Clinical Study on BIFICO Accelerating Postoperative Liver Function Recovery in Patients With Hepatocellular CarcinomaCompletedNCT05178524Not applicable
- GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular CarcinomaActive, not recruitingNCT05178043Phase 2
- Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular CarcinomaStatus unknownNCT05173610Phase 2
- Surufatinib in Advanced Hepatocellular Carcinoma Based on Single-cell Sequencing of Tumor SamplesStatus unknownNCT05171439Phase 2
- Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma PatientsCompletedNCT05171335Phase 2
- Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCCStatus unknownNCT05171309Phase 2
- Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.TerminatedNCT05171166Phase 2/3
- Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular CarcinomaStatus unknownNCT05166772Phase 2
- HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTTCompletedNCT05166239Phase 2
- Donafenib Plus Sintilimab for Advanced HCCCompletedNCT05162352Phase 2
- Donafenib Combined With TACE as Adjuvant Therapy of Patients With Hepatocellular CarcinomaStatus unknownNCT05161143Phase 2
- Y-90 Versus SBRT for Inoperable HCCWithdrawnNCT05157451Phase 2
- Yang Yin Fu Zheng Jie Du Therapy in HBV Associated Hepatocellular Carcinoma Based on the Platelet Count/Splenic Length-Diameter RatioStatus unknownNCT05154812Early Phase 1
- Fu Zheng Jie Du Hua Yu Principle For Treatment Of Severe HBV Related Hepatocellular Carcinoma (FZJDHYPFTOSHBVHCC)Status unknownNCT05152498Early Phase 1
- Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular CarcinomaActive, not recruitingNCT05148572
- Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation TherapyTerminatedNCT05137899Phase 2
- HAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE FailureStatus unknownNCT05135364Phase 2
- Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCCStatus unknownNCT05134532Phase 2
- Clinical Study of the Efficacy and Safety of Transhepatic Arterial Chemoembolization Combined With Tislelizumab and Lenvatinib in Patients With Advanced Unresectable Hepatocellular CarcinomaStatus unknownNCT05131698Early Phase 1
- Influence of Social Determinants of Health on the Management of HCC in the French National Cohort Study CHIEFActive, not recruitingNCT05128123
- Pressure-enabled Delivery in Radioembolization (TriNav Study)CompletedNCT05128032Not applicable
- The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective StudyCompletedNCT05121571Not applicable
- BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid TumorsActive, not recruitingNCT05120271Phase 1/2
- A Multicenter RCT Study of 3DV Technology in the Diagnosis and Treatment of PLCStatus unknownNCT05118451Not applicable